I ran across this comprehensive article about the emergence of new myeloma immunotherapies on OncLive.com over the weekend. It features a who's who of myeloma experts. I'm having some technical difficulties posting the article. Remember Dr. Noopur Raje? She was kind enough to fly down to speak at this year's Pat's Myeloma Beach Party. Dr.
Wednesday our Cure Talk panel was fortunate to spend over an hour with Emory University's Dr. Sagar Lonial, a well known myeloma specialist. The focus was on ways to treat high risk multiple myeloma patients most effectively. I was pleased by how well the hour went. No real technical glitches. Intelligent questions from our panel
Here's an excerpt from an interesting and comprehensive article from the July edition of Clinical Oncology News, How I Manage: Evolving Role of Autologous Transplantation in Multiple Myeloma. It features the views of myeloma specialist, Sagar Lonial, with the Winship Cancer Institute at Emory University in Atlanta: There is some discussion that, perhaps, patients
Dr. Sagar Lonial, myeloma specialist and professor at Emory University's School of Medicine in Atlanta, recently wrote a helpful and easy to understand primer about how genetics fit in with today's fast advancing myeloma research and therapy. The lynchpin to fully understanding and implementing cutting edge genetic research: the Multiple Myeloma Research Foundation's (MMRF) ambitious
One of Andrew Schorr's better clips featuring Dr. Craig Hofmeister, Ohio State University Comprehensive Cancer Center, and Dr. Sagar Lonial, Winship Cancer Institute of Emory University, discussing different myeloma therapies including stem cell transplants, non-transplants, targeted and combination therapies: Transplant or Targeted Therapy: What's the Mainstay for Treatment in Multiple Myeloma?